Argenx Se (ARGX) Non-Current Assets (2015 - 2026)
Argenx Se's (ARGX) quarterly Non-Current Assets came in at $2.0 billion in Q2 2026, up 100.03% on a YoY basis from $981.8 million in Q2 2025, and up 10.09% quarter-over-quarter from $1.8 billion in Q4 2025.
Powered by 
Analysis
Argenx Se (ARGX) Non-Current Assets (2015 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported Non-Current Assets for 12 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 100.03% year-over-year to $2.0 billion; the trailing twelve-month figure through Jun 2026 stood at -$10695.7 billion (changed N/A YoY), and the FY2025 full-year result was $1.8 billion, up 100.04% from the prior year.
- Non-Current Assets grew to $2.0 billion in Q2 2026 per ARGX's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $360.1 billion in Q4 2022 and bottomed at -$5822.6 billion in Q2 2025.
- Historically, Non-Current Assets has averaged -$1148.2 billion across 5 years, with a median of $502.3 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets sank 1164813.61% in 2024, then jumped 100.04% in 2025.
- Over 5 years, Non-Current Assets stood at $360.1 billion in 2022, then sank by 99.88% to $418.7 million in 2023, then tumbled by 1164813.61% to -$4876.9 billion in 2024, then surged by 100.04% to $1.8 billion in 2025, then increased by 10.09% to $2.0 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $2.0 billion, $1.8 billion, and -$5822.6 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Argenx Se | 58.53 Bn | 53.35 Bn | 1.37 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96 Bn |
| Dec 31, 2025 | 1.78 Bn |
| Jun 30, 2025 | -5,822.56 Bn |
| Dec 31, 2024 | -4,876.90 Bn |
| Jun 30, 2024 | 532.77 Mn |
| Dec 31, 2023 | 418.72 Mn |
| Jun 30, 2023 | 502.28 Mn |
| Dec 31, 2022 | 360.06 Bn |
| Jun 30, 2022 | 319.95 Mn |
| Dec 31, 2021 | 307.30 Bn |
| Jun 30, 2021 | 348.36 Mn |
| Dec 31, 2020 | 216.26 Bn |
| Jun 30, 2020 | 71.45 Mn |
| Dec 31, 2019 | 66.55 Mn |
| Jun 30, 2019 | 55.35 Mn |
| Dec 31, 2018 | 6.87 Mn |
| Jun 30, 2018 | 5.08 Mn |
| Dec 31, 2017 | 4.83 Mn |
| Jun 30, 2017 | 3.93 Mn |
| Dec 31, 2016 | 4.30 Mn |
API Access
Argenx Se Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();